Showing results (211-220 of 558) with videos related to
Sort By:
Pageof 56
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson diseaseM Emre, U K Rinne, A Rascol, et al.Journal of Neurochemistry|September 1, 1984
Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjectsC Llorens-Cortes, F Javoy-Agid, Y Agid, et al.Journal of Neurology|February 1, 1992
Brain muscarinic cholinergic receptors in Huntington's diseaseK W Lange, F Javoy-Agid, Y Agid, et al.Revue Neurologique|January 1, 1985
[In vivo study of central serotoninergic receptors in man using positron tomography]J C Baron, Y Samson, D Comar, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1987
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systemsM Ruberg, A Villageois, A M Bonnet, et al.Neurology|March 1, 1997
Low-dose clozapine improves dyskinesias in Parkinson's diseaseF Durif, M Vidailhet, F Assal, et al.Sbornik Lekarsky|February 28, 2001
The effects of apomorphine on attentional processing in Parkinson's diseaseE Růzicka, F el Massioui, B Pillon, et al.European Neurology|June 23, 2005
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatmentD J Brooks, Y Agid, K Eggert, et al.Annals of Neurology|June 1, 1990
Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?E C Hirsch, C Duyckaerts, F Javoy-Agid, et al.Neuroscience Letters|January 16, 1989
Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatumE C Hirsch, A M Graybiel, L B Hersh, et al.Pageof 56